Author:
Janus Guus J. M.,Franken Anton A. M.,Harsevoort Arjan G. J.,Dommisse Anne Marieke V.
Publisher
Springer International Publishing
Reference64 articles.
1. Monti E, Mottes M, Fraschini P, Brunelli P, Forlino A, Venturi G, Doro F, Perlini S, Cavarzere P, Antoniazzi F. Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag. 2010;6:367–81.
2. Shapiro JR, Germain-Lee EL. Osteogenesis imperfecta: effecting the transition from adolescent to adult medical care. J Musculoskelet Neuronal Interact. 2012;12:24–7.
3. Edouard T, Glorieux FH, Ruach F. Predictors and correlates of Vit D status in children and adolescents with osteogenesis imperfect. J Clin Endocrinol Metab. 2011;96:3193–8.
4. Plante L, Veilleux LN, Glorieux FH, Weiler H, Rauch F. Effect of high-dose vitamin D supplementation on bone density in youth with osteogenesis imperfect: a randomized controlled trial. Bone. 2016;86:36–42.
5. Carmel AS, Shieh A, Bang H, Bockman RS. The 25(OH)D level needed to maintain a favorable bisphosphonate is > 33 ng/ml. Osteoporosis Int. 2012;23:2479–87.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献